SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-111082
Filing Date
2016-07-01
Accepted
2016-07-01 12:23:48
Documents
1
Period of Report
2016-08-11
Effectiveness Date
2016-07-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A v443254_def14a.htm DEF 14A 563596
  Complete submission text file 0001144204-16-111082.txt   564757
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35076 | Film No.: 161745683
SIC: 2835 In Vitro & In Vivo Diagnostic Substances